The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Curacef duo, 50 mg/ml / 150 mg/ml, Suspension for Injection for Cattle

Virbac S.A.VPA10988/092/001

Main Information

Trade NameCuracef duo, 50 mg/ml / 150 mg/ml, Suspension for Injection for Cattle
Active SubstancesCeftiofur hydrochloride
Dosage FormSuspension for injection
Licence HolderVirbac S.A.
License Holder Address1ère avenue
2065 M LID
06516 Carros
Licence NumberVPA10988/092/001

Group Information

ATC CodeQJ01DD Third-generation cephalosporins
Therapeutic ClassAntibacterial


License statusAuthorised
Licence Issued01/08/2014
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back